🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Microvention-Terumo clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our USA, Germany, France, UK, Italy, Belgium and Spain registers with Microvention-Terumo as lead sponsor. Synced 27 Sep 2026
8Current trials
2Recruiting now
0Drugs in these trials
7Trial registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Microvention-Terumo is the lead sponsor of 8 current clinical trials in our USA, Germany, France, UK, Italy, Belgium and Spain registers. 2 are recruiting patients now. The most common phase is Observational. The most-studied condition is Intracranial Aneurysm.

ClinicalTrials.gov trials by status

  • Recruiting225%
  • Active, closed450%
  • By invitation225%

Trials by phase

  • Observational563%
  • Not applicable338%
01

Clinical trials sponsored by Microvention-Terumo

8 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Microvention AnEurysm & STroke Real-life Data cOllection
NCT06494436 · ClinicalTrials.gov ↗ · Intracranial Aneurysm, Intracranial Aneurysm, Wide Neck Aneurysm, Large Neck Aneurysm Lesion, Aneurysmal Subarachnoid Hemorrhage
Observational Recruiting 2024-12 Spain
European, Multi-center, Exploratory Trial to Assess WEB Versus Other Endovascular Treatment in Ruptured Aneurysms.
NCT06511245 · ClinicalTrials.gov ↗ · Ruptured Aneurysm
Not applicable Recruiting 2024-10 France
Post-Market Surveillance Study to Evaluate the Long-Term Safety and Effectiveness of the LVIS Device
NCT05453240 · Intracranial Aneurysms
Observational By invitation 2020-11 USA
Complex Aneurysm Registry - Real-World Evidence Data Collection Intracranial Aneurysm Treatment Devices
NCT06215105 · Aneurysm Cerebral
Observational By invitation 2024-01 USA
FRED/ FRED Jr/ FRED X Intracranial Aneurysm Treatment Study
NCT03920358 · ClinicalTrials.gov ↗ · Intracranial Aneurysm
Observational Active, closed 2019-04 Germany
LVIS™ Evo™ and HydroCoil® Embolic System for Intracranial Aneurysm Treatment
NCT04999423 · ClinicalTrials.gov ↗ · Intracranial Aneurysm
Observational Active, closed 2022-01 UK, Germany, France, Italy, Belgium
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
NCT05409989 · ClinicalTrials.gov ↗ · Intracranial Aneurysm
Not applicable Active, closed 2022-09 USA
Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device
NCT04839705 · ClinicalTrials.gov ↗ · Wide Neck Bifurcation Intracranial Aneurysms
Not applicable Active, closed 2022-08 USA

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Microvention-Terumo trials

8 conditions
Intracranial Aneurysm4Intracranial Aneurysms1Aneurysm Cerebral1Wide Neck Bifurcation Intracranial Aneurysms1Ruptured Aneurysm1Intracranial Aneurysm, Wide Neck Aneurysm, Large Neck Aneurysm Lesion1Aneurysmal Subarachnoid Hemorrhage1Ischemic Stroke1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in USA40
Clinical trials in Germany20
Clinical trials in France21
Clinical trials in UK10
Clinical trials in Italy10
Clinical trials in Belgium10
Clinical trials in Spain11

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Intracranial Aneurysm

SponsorTrials
Medtronic Neurovascular Clinical Affairs4
Stryker Neurovascular2
University Hospital, Geneva2
Acandis2
Montefiore Medical Center1

Sponsors with the most current trials registered for this condition.

05

Questions about Microvention-Terumo trials

How many clinical trials does Microvention-Terumo sponsor?

Microvention-Terumo is the lead sponsor of 8 current trials on ClinicalTrials.gov in our USA, Germany, France, UK, Italy, Belgium and Spain registers, as of the registry sync on 27 September 2026. Completed and withdrawn studies are not counted.

Are Microvention-Terumo trials recruiting?

Yes. 2 of its 8 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 27 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.